Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care - Wikidata - awgldk - TriplyDB

Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care

Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care

http://www.wikidata.org/entity/Q28546416

about

A genomic study on distribution of human leukocyte antigen (HLA)-A and HLA-B alleles in Lak population of Iran.HLA Association with Drug-Induced Adverse Reactions.

P2860

Q37438578-16BD95B1-BB5A-4AE0-B450-EE98F0A50C26 Q47553722-2EB9726C-4A15-447C-A47E-FD5CC513D24A

P2860

Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care

http://www.wikidata.org/entity/Q28546416

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Comparison of methods for in-h ...... hypersensitivity in HIV-1 care

@ast

Comparison of methods for in-h ...... hypersensitivity in HIV-1 care

@en

Comparison of methods for in-h ...... hypersensitivity in HIV-1 care

@nl

type

label

Comparison of methods for in-h ...... hypersensitivity in HIV-1 care

@ast

Comparison of methods for in-h ...... hypersensitivity in HIV-1 care

@en

Comparison of methods for in-h ...... hypersensitivity in HIV-1 care

@nl

prefLabel

Comparison of methods for in-h ...... hypersensitivity in HIV-1 care

@ast

Comparison of methods for in-h ...... hypersensitivity in HIV-1 care

@en

Comparison of methods for in-h ...... hypersensitivity in HIV-1 care

@nl

P1433

Q28546416-E591F2DF-25B3-40C9-A02C-87B0D7B87B4C

P1476

Q28546416-901BB29D-2DC3-447C-90ED-E8C237899447

P2093

Q28546416-15C8B9D4-9A1B-4587-8706-3D3055F81C89

Q28546416-1A73ECDC-0904-4C32-A188-8FA8C0029CEF

Q28546416-39297FC3-3A21-42D2-B09A-600D31A69432

Q28546416-49FD8BB5-0DEC-465B-9707-9DB740B144ED

Q28546416-53B74402-074D-41AC-8E3A-2FA72AA6B3AB

Q28546416-80A60C22-623E-4245-B133-33D1E4342FBD

Q28546416-A65B488D-6EF4-4397-85D7-80BC9032DCF7

Q28546416-AF58A8C2-EDBB-49E9-BB08-9A5D95709643

Q28546416-AFA298E1-157E-4892-94C2-B7A84DBF0C18

Q28546416-B818648B-D250-47A1-B0A0-E4C9AEBF0DEF

P2860

Q28546416-00F90D40-4CEA-46B7-B599-3C5D911E8C90

Q28546416-053112EE-380A-4DF3-963D-42000D3600AF

Q28546416-0C041625-29E1-4699-B8FE-762FE8A2C3CB

Q28546416-2866F7C2-40B0-4880-B530-DEF748DFF76C

Q28546416-2AA1BFAA-324A-461F-ABA0-2C465C18C081

Q28546416-2C272228-9847-4C69-B0C2-AE79F9F7C955

Q28546416-441C593D-0365-4FE2-9BA0-6A9BA3063CF3

Q28546416-68818106-8EB1-488C-A5DD-FFC94F13924C

Q28546416-839314C0-6721-4539-A892-E05B16CF8808

Q28546416-8EAB016D-505F-4F18-B3C7-27598C440296

P304

Q28546416-445E4523-891E-4F6F-A097-D41BDFA508D5

P31

Q28546416-9A6C3D34-F54F-484B-9F6F-AE47585E4E29

P356

Q28546416-CFDE379E-9D7E-4DC8-8D43-AC2788E9A573

P407

Q28546416-B6BE1AD7-F731-41C2-BF8D-DDA0FA4DDD19

P433

Q28546416-C137FB61-A59B-44E3-AFB5-F61F1EEF205E

P478

Q28546416-687A6B51-5E24-4483-865F-5231DC3D1967

P50

Q28546416-1509F187-2806-465F-BE29-93501EE905BB

Q28546416-4E0E9048-4B22-4497-B758-9A908851F9F2

Q28546416-603AE151-344F-419C-BE0C-0983FF035415

Q28546416-B1167817-DC97-4D27-87FE-07A55C47A591

Q28546416-BEEA033F-3D69-4D4C-8C7C-9C48EACFDE10

Q28546416-F733A3E1-0F27-4EC3-9F46-605CCD8B1B6C

P577

Q28546416-9C728FF6-8DFF-47D1-AF18-16B089F0201F

P5875

Q28546416-BFC57F19-7E25-4EEA-8986-D6B578C3E398

P698

Q28546416-C4B5664D-D102-47E2-9661-CD01F8C2A127

P932

Q28546416-F9B16B2D-C744-4680-B896-7F41054C93A1

P356

JOURNAL.PONE.0123525

P1433

P1476

Comparison of methods for in-h ...... hypersensitivity in HIV-1 care

@en

P2093

Chris Verhofstede

http://www.w3.org/2001/XMLSchema#string

Dirk Vogelaers

http://www.w3.org/2001/XMLSchema#string

Erica Sermijn

http://www.w3.org/2001/XMLSchema#string

Eva Malatinkova

http://www.w3.org/2001/XMLSchema#string

Jan Philippé

http://www.w3.org/2001/XMLSchema#string

Jean Ruelle

http://www.w3.org/2001/XMLSchema#string

Kabamba Kabeya

http://www.w3.org/2001/XMLSchema#string

Karen Vervisch

http://www.w3.org/2001/XMLSchema#string

Maja Kiselinova

http://www.w3.org/2001/XMLSchema#string

Paul Coucke

http://www.w3.org/2001/XMLSchema#string

P2860

Developments in CD4 and viral load monitoring in resource-limited settings

Abacavir pharmacogenetics--from initial reports to standard of care

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

A near-fatal hypersensitivity reaction to abacavir: case report and literature review.

High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.

The Pharmacogenomic HLA Biomarker Associated to Adverse Abacavir Reactions: Comparative Analysis of Different Genotyping Methods.

HLA-B locus sequence-based typing.

Flow cytometry analysis with a new FITC-conjugated monoclonal antibody-3E12 for HLA-B*57:01 rapid screening in prevention of abacavir hypersensitivity in HIV-1-infected patients.

P304

e0123525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0123525

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Linos Vandekerckhove

Stéphane De Wit

Ward De Spiegelaere

Marie-Paule Emonds

Vicky Van Sandt

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275026614

http://www.w3.org/2001/XMLSchema#string

P698

25874872

http://www.w3.org/2001/XMLSchema#string

P932

4398410

http://www.w3.org/2001/XMLSchema#string